Alexander Mark Schobel - Net Worth and Insider Trading
Alexander Mark Schobel Net Worth
The estimated net worth of Alexander Mark Schobel is at least $3 Million dollars as of 2024-05-14. Alexander Mark Schobel is the Chief Innovation/Tech Officer of Aquestive Therapeutics Inc and owns about 984,476 shares of Aquestive Therapeutics Inc (AQST) stock worth over $3 Million. Details can be seen in Alexander Mark Schobel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alexander Mark Schobel has not made any transactions after 2024-03-15 and currently still holds the listed stock(s).
Transaction Summary of Alexander Mark Schobel
Alexander Mark Schobel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alexander Mark Schobel owns 1 companies in total, including Aquestive Therapeutics Inc (AQST) .
Click here to see the complete history of Alexander Mark Schobel’s form 4 insider trades.
Insider Ownership Summary of Alexander Mark Schobel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AQST | Aquestive Therapeutics Inc | 2024-03-15 | director & Chief Innovation/Tech Officer |
Alexander Mark Schobel Latest Holdings Summary
Alexander Mark Schobel currently owns a total of 1 stock. Alexander Mark Schobel owns 984,476 shares of Aquestive Therapeutics Inc (AQST) as of March 15, 2024, with a value of $3 Million.
Latest Holdings of Alexander Mark Schobel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics Inc | 2024-03-15 | 984,476 | 3.27 | 3,219,237 |
Holding Weightings of Alexander Mark Schobel
Alexander Mark Schobel Form 4 Trading Tracker
According to the SEC Form 4 filings, Alexander Mark Schobel has made a total of 8 transactions in Aquestive Therapeutics Inc (AQST) over the past 5 years, including 1 buys and 7 sells. The most-recent trade in Aquestive Therapeutics Inc is the sale of 50,000 shares on March 15, 2024, which brought Alexander Mark Schobel around $300,000.
Insider Trading History of Alexander Mark Schobel
- 1
Alexander Mark Schobel Trading Performance
GuruFocus tracks the stock performance after each of Alexander Mark Schobel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alexander Mark Schobel is -1.2%. GuruFocus also compares Alexander Mark Schobel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alexander Mark Schobel within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alexander Mark Schobel's insider trading performs compared to the benchmark.
Performance of Alexander Mark Schobel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.63 | | | | | |
| Relative Return to S&P 500(%) | -12.21 | | | | | |
Alexander Mark Schobel Ownership Network
Alexander Mark Schobel Owned Company Details
What does Aquestive Therapeutics Inc do?
Who are the key executives at Aquestive Therapeutics Inc?
Alexander Mark Schobel is the director & Chief Innovation/Tech Officer of Aquestive Therapeutics Inc. Other key executives at Aquestive Therapeutics Inc include Chief Medical Officer Carl N Kraus , SVP & Research & Development Stephen Wargacki , and SVP & Operations Cassie Jung .
Aquestive Therapeutics Inc (AQST) Insider Trades Summary
Over the past 18 months, Alexander Mark Schobel made 2 insider transaction in Aquestive Therapeutics Inc (AQST) with a net sale of 75,000.
In summary, during the past 3 months, insiders sold 75,000 shares of Aquestive Therapeutics Inc (AQST) in total and bought 0 shares, with a net sale of 75,000 shares. During the past 18 months, 75,000 shares of Aquestive Therapeutics Inc (AQST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 75,000 shares.
Aquestive Therapeutics Inc (AQST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aquestive Therapeutics Inc Insider Transactions
Alexander Mark Schobel Mailing Address
Above is the net worth, insider trading, and ownership report for Alexander Mark Schobel. You might contact Alexander Mark Schobel via mailing address: 30 Technology Drive, Warren Nj 07059.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
